Hemodynamic effects of pimobendan given orally in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

New Positive Inotropic Agents in the Treatment of Congestive Heart Failure

1986 • 402 citations

New Positive Inotropic Agents in the Treatment of Congestive Heart Failure

1986 • 337 citations

Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.

1986 • 175 citations

Inotropic drugs and their mechanisms of action

1984 • 151 citations

Positive Inotropic Agents

1984 • 95 citations

Effects of new inotropic agents on Ca++ sensitivity of contractile proteins.

1986 • 92 citations

Phosphodiesterase-inhibiting properties of newer inotropic agents.

1986 • 89 citations

Cardiovascular profile of pimobendan, a benzimidazole-pyridazinone derivative with vasodilating and inotropic properties

1986 • 79 citations

UD-CG 115 ? a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle

1984 • 74 citations

Comparative Mechanisms for Contraction of Cardiac and Skeletal Muscle

1980 • 65 citations

Effect on contractility of skinned fibres from mammalian heart and smooth muscle by a new benzimidazole derivative, 4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methy l-3(2H )- pyridazinone.

1984 • 56 citations

Hemodynamic Profile of the Cardiotonic Agent Pimobendan

1989 • 55 citations

Evaluating the efficacy of new inotropic agents

1984 • 45 citations

Influence of association and of positive inotropic drugs on calcium binding to cardiac troponin C

1987 • 36 citations

Cardiovascular Effects and Plasma Level Profile of Pimobendan (UD-CG 115 BS) and Its Metabolite UD-CG 212 in Patients with Congestive Heart Failure After Single and Repeated Oral Dosing

1989 • 36 citations

Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts.

1985 • 36 citations

Cardiovascular effects of the positive inotropic agents pimobendan and sulmazole in vivo.

1985 • 33 citations

Pimobendane (UD-CG115 BS) in Chronic Congestive Heart Failure

1988 • 31 citations

Systemic haemodynamic actions of pimobendan (UD‐CG 115 BS) and its O‐demethylmetabolite UD‐CG 212 Cl in the conscious pig

1987 • 31 citations

Pimobendan Increases Survival of Cardiomyopathic Hamsters

1989 • 26 citations

Cardiovascular Profile of UDCG 115 BS-Pimobendane and Reversibility of Catecholamine Subsensitivity in Severe Congestive Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy

1989 • 24 citations

Cardiovascular Profile of UDCG 115 BS-Pimobendane and Reversibility of Catecholamine Subsensitivity in Severe Congestive Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy

1989 • 22 citations

Hemodynamic Effects of Intravenous Pimobendan in Patients with Left Ventricular Dysfunction

1989 • 20 citations

Effects of Pimobendan (UD-CG 115) on the Contractile Function of the Normal and “Postischemic” Canine Myocardium

1988 • 19 citations

Cardiovascular effects of UD-CG 212 CL, a metabolite of pimobendan, in anaesthetized pigs

1987 • 18 citations

Usefulness of pimobendan in the treatment of heart failure.

1986 • 18 citations

Effects of some cardiotonic agents on contractility of skinned fibers from mammalian heart.

1987 • 18 citations

Myothermal economy of rat myocardium, Chronic adaptation versus acute inotropism

1986 • 17 citations

Influence of enoximone and UDCG-115 on coronary hemodynamics in idiopathic dilated cardiomyopathy

1988 • 9 citations

Acute Effects of Intraveneous UD-CG 115 BS (Pimobendan) on the Cardiovascular System and Left Ventricular Pump Function

1989 • 7 citations